A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Clinical trial NCT05153499 · TERMINATED

Trial details

NCT number: NCT05153499
Sponsor: Finch Research and Development LLC.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent C. Difficile Infection

Start date: 2021-11-15
Primary completion: 2023-02-24
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.